Exagen (XGN) PT Raised to $10 at Cantor Fitzgerald Jul 30, 2025 06:58AM
Exagen (XGN) PT Lowered to $7 at Cantor Fitzgerald May 15, 2025 07:29AM
Cantor Fitzgerald newsletter says Elutia best, Anteris worst performer Mar 17, 2025 07:38AM
Exagen (XGN) PT Lowered to $8 at Cantor Fitzgerald Mar 10, 2025 07:18AM
Exagen (XGN) PT Raised to $7 at Cantor Fitzgerald May 14, 2024 06:35AM


Sep 12, 2023 04:05PM Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
Nov 8, 2022 04:05PM Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Nov 8, 2022 04:05PM Exagen Inc. to Participate in Fourth Quarter Investor Conferences
May 18, 2022 06:13AM Cantor Fitzgerald Reiterates Overweight Rating, $19 Price Target on Exagen (XGN) on Alivio Health Agreement
Mar 23, 2022 07:51AM Exagen (XGN) PT Lowered to $19 at Cantor Fitzgerald on Weaker Guidance, but Analyst Maintained Overweight Rating and Positive Outlook, "Would Encourage Investors to Acquire Shares" at Current Valuatio
Sep 13, 2021 04:15PM Exagen Inc. to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
Sep 13, 2021 04:15PM Exagen Inc. to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
Mar 25, 2021 04:15PM Exagen Inc. Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Mar 25, 2021 04:15PM Exagen Inc. Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Mar 23, 2021 05:59AM Exagen Inc (XGN) Prices 3.7M Share Common Offering at $16.25/Sh
Mar 22, 2021 10:01PM Exagen Inc. Announces Pricing of Public Offering of Common Stock
Mar 22, 2021 10:01PM Exagen Inc. Announces Pricing of Public Offering of Common Stock
Mar 22, 2021 04:06PM Exagen Inc (XGN) Announces Proposed Public Offering of Common Stock
Mar 22, 2021 04:05PM Exagen Inc. Announces Proposed Public Offering of Common Stock
Mar 22, 2021 04:05PM Exagen Inc. Announces Proposed Public Offering of Common Stock
Mar 17, 2021 07:46AM Exagen (XGN) PT Raised to $24 at Cantor Fitzgerald
Jan 19, 2021 08:33AM Exagen (XGN) PT Raised to $22 at Cantor Fitzgerald on Testing Strength
Sep 3, 2020 04:05PM Exagen to Participate in 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
Sep 3, 2020 04:05PM Exagen to Participate in 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
Jun 2, 2020 09:28AM Pre-Open Stock Movers 06/02: (MGI) (WU) (SWBI) Higher; (PUMP) (INVH) (GH) Lower (more...)
Jun 1, 2020 05:30PM After-Hours Stock Movers 6/1: (MGI) (KLDO) (XGN) HIGHER; (PUMP) (INVH) (GH) LOWER (more...)
Jun 1, 2020 04:12PM Cantor Fitzgerald Assumes Exagen (XGN) at Overweight
Mar 26, 2020 06:52AM Exagen (XGN) PT Lowered to $19 at Cantor Fitzgerald
Oct 14, 2019 07:36AM Cantor Fitzgerald Starts Exagen (XGN) at Overweight
Sep 23, 2019 01:36PM Exagen Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Sep 23, 2019 01:36PM Exagen Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Sep 19, 2019 12:53PM Exagen (XGN) IPO Opens 20% Higher
Sep 19, 2019 05:49AM Exagen Inc (XGN) Prices 3.6M Share IPO at $14/Sh
Sep 18, 2019 07:14PM Exagen Inc. Announces Pricing of Initial Public Offering